What Researchers Did
Researchers retrospectively reviewed the medical records of 23 patients treated with definitive or postoperative radiotherapy for sinonasal undifferentiated carcinoma at the University of Florida between 1992 and 2010 to evaluate its long-term effectiveness.
What They Found
The actuarial 5-year progression-free survival was 42%, cause-specific survival was 43%, and overall survival was 32%. Five-year local control was 74%, and 13% of patients experienced severe complications, including unilateral eye removal or osteoradionecrosis.
What This Means for Canadian Patients
For Canadian patients with sinonasal undifferentiated carcinoma, this study suggests that radiotherapy can offer some disease control, but survival rates remain challenging. A multimodal treatment approach, potentially combining surgery and radiotherapy, may be considered to optimize outcomes while being mindful of potential severe complications.
Canadian Relevance
This study was conducted at the University of Florida and has no direct Canadian connection.
Study Limitations
The study's retrospective design and small sample size of 23 patients limit the generalizability of its findings.